Meeting materials of Hebang Biotech\'s 3rd Extraordinary General Meeting of Shareholders in 2024
Notice of Hebang Biotech on convening the 3rd Extraordinary General Meeting of Shareholders in 2024
Sichuan Hebang Biotechnology's announcement on progress of external investment.
Announcement on the share repurchase of Sichuan Hebang Biotechnology Co., Ltd. and the shareholding of the top ten shareholders and the top ten unrestricted shareholders.
Announcement on the progress of the wholly-owned subsidiary of Sichuan Hebang Biotechnology's external investment.
Announcement on the share repurchase of Sichuan Hebang Biotechnology Co., Ltd. and the shareholding of the top ten shareholders and the top ten unrestricted shareholders.
Announcement of Resolutions of Hebang Biotech's 2023 Annual General Meeting of Shareholders
Legal Opinion of Beijing Guofeng Law Firm on the 2023 Annual General Meeting of Shareholders of Hebang Biotech
Hebang Biotech's 2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of the resolution of the first shareholders' meeting of Hebang Biotech Phase III Employee Stock Ownership Plan
Announcement of Hebang Biotech on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions for share repurchases
Hebang Biotech's announcement on the completion of the non-transactional transfer of the third phase of the employee stock ownership plan
Hebang Biotech's indicative announcement on financial data updates in application documents such as prospectus for issuing convertible corporate bonds to unspecified targets
Hebang Biotech's announcement on the progress of implementation of the third phase of the employee stock ownership plan
Sichuan Hebang Biotechnology Co., Ltd. prospectus for issuing convertible corporate bonds to unspecified targets (registration draft) (exempted version)
Beijing Guofeng Law Firm's Supplementary Legal Opinion No. 6 on Sichuan Hebang Biotechnology Co., Ltd.'s application to issue convertible corporate bonds to unspecified targets
Huaxi Securities Listing Sponsorship Letter on the Issuance of Convertible Corporate Bonds by Sichuan Hebang Biotechnology Co., Ltd. to unspecified targets (registration draft)
Huaxi Securities's issuance letter of sponsorship for the issuance of convertible corporate bonds by Sichuan Hebang Biotechnology Co., Ltd. to unspecified targets (registration draft)
Sichuan Hebang Biotechnology Co., Ltd. Internal Control Evaluation Report
Hebang Biotech Board Audit Committee's 2023 Performance Report
No Data